top of page
Aruwon Limited
Strategic consultancy for life science companies and investors
Investor Case Studies
Private Equity
US-based Multinational
Private equity client commissioned Aruwon to perform a review of the key investments in a life science investment portfolio. For each company Aruwon provided an analysis of the technology, market opportunity, competitive landscape valuation and potential value inflexion points.
Private Equity
US-based Multinational
Private equity client commissioned Aruwon to perform an analysis of analysis of the burgeoning GLP-1 market. The analysis was in focussed on the supply and demand pressures surrounding the manufacture and fill-finishing of the GLP-1 peptide in the light of Novo Nordisk's acquisition of Catalent's fill-finish plants.
Strategic consultancy for life science companies and investors
bottom of page